Home
Arch Venture Fund X Overage, 10% Owner: Sana Biotechnology SANA Buy · Filed 24/02/12
Trade details
- Type
- Insider buy
- Amount
- $3,999,996
- Shares · price
- 727,272 sh · $5.50 a share
- Held after
- 12,446,022 sh
- Trade date
- 24/02/08
- Filed
- 24/02/12
- Days to filing
- 4 days
First buy since 2023
- Insiders buying this week
- 15 insiders
- Holding change
- +6.2%
Sana Biotechnology trades, last 26 weeks
What else happened in Sana Biotechnology around then
Filed or reported within 30 days of the trade day · 24/01/09~24/03/09Arch Venture Fund X Overage's recent trades
- Arch Venture Fund X Overage
BuyNeumora Therapeutics
BuyNeumora Therapeutics
NMRA
$5M
1,915,700 sh
$5M
Filed 25/10/29
Traded 25/10/27
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$2.1M
133,333 sh
$2.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$1.1M
66,667 sh
$1.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund X Overage
BuyPrime Medicine
BuyPrime Medicine
PRME
$20M
3,200,000 sh
$20M
Filed 24/02/20
Traded 24/02/15
